BioCryst Pharmaceuticals, Inc.
Durham
NC
27703
United States
605 articles about BioCryst Pharmaceuticals, Inc.
-
Biocryst Pharmaceuticals Elects Stanley C. Erck to its Board of Directors
12/23/2008
-
Biocryst Pharmaceuticals Continues Forodesine HCl Program in Chronic Lymphocytic Leukemia
12/22/2008
-
Biocryst Pharmaceuticals to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
12/5/2008
-
Biocryst Pharmaceuticals Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
10/28/2008
-
Biocryst Pharmaceuticals Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza Management to Host Conference Call at 8:30 a.m. Eastern Time Today to Discuss Results
10/27/2008
-
Biocryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
10/24/2008
-
Biocryst Pharmaceuticals Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
10/20/2008
-
Biocryst Pharmaceuticals Cuts Staff by 20 Percent
10/6/2008
-
Biocryst Pharmaceuticals Autoimmune Drug Stalls in Clinical Trial
9/5/2008
-
Biocryst Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Corporate Update
8/7/2008
-
Biocryst Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 7, 2008
7/31/2008
-
Biocryst Pharmaceuticals Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study; Primary Endpoint Met
7/28/2008
-
Biocryst Pharmaceuticals Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
7/10/2008
-
William P. Sheridan Appointed Chief Medical Officer of Biocryst Pharmaceuticals
6/18/2008
-
Biocryst Pharmaceuticals Reports First Quarter 2008 Financial Results and Clinical Update
5/9/2008
-
Biocryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
5/2/2008
-
Biocryst Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
3/4/2008
-
Biocryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
2/29/2008
-
Biocryst Pharmaceuticals Updates Peramivir Clinical Development Plan; Company Will Not Continue Phase III
1/24/2008
-
Biocryst Pharmaceuticals Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer
1/11/2008